| Robert J Delaney, CRNA | |
|
1001 Towson Ave, Fort Smith, AR 72901-4921 | |
| (479) 441-4000 | |
| Not Available |
| Full Name | Robert J Delaney |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 1001 Towson Ave, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295869774 | NPI | - | NPPES |
| 191438001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | C002902 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Johnson Regional Medical Center | Clarksville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Arkansas Anesthesiology Associates P.a. | 0648179291 | 29 |
| Johnson Regional Medical Center | 1658360284 | 12 |
| Ans Services Of Arkansas Pa | 4486002599 | 38 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Western Arkansas Anesthesiology Associates P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548202294 PECOS PAC ID: 0648179291 Enrollment ID: O20040102000767 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508800962 PECOS PAC ID: 7911802079 Enrollment ID: O20040331000754 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Mercy Hospital Ozark |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1275504128 PECOS PAC ID: 3678467412 Enrollment ID: O20040428001328 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | St Vincent Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134176480 PECOS PAC ID: 5698758803 Enrollment ID: O20040622000224 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Johnson Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396794525 PECOS PAC ID: 1658360284 Enrollment ID: O20040702000283 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Mercy Hospital Waldron |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1912978875 PECOS PAC ID: 5597658005 Enrollment ID: O20061104000294 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1760453633 PECOS PAC ID: 0244135705 Enrollment ID: O20061104000304 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Mercy Hospital Booneville |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1992133714 PECOS PAC ID: 1951530385 Enrollment ID: O20140312001275 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Southern Regional Anesthesiology Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902231673 PECOS PAC ID: 2961633870 Enrollment ID: O20140318000757 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Arkansas Liver And Gastroenterology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932586260 PECOS PAC ID: 1557672409 Enrollment ID: O20150618000749 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Entity Name | Ans Services Of Arkansas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699558387 PECOS PAC ID: 4486002599 Enrollment ID: O20231130001281 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert J Delaney, CRNA 1001 Towson Ave, Fort Smith, AR 72901-4921 Ph: (479) 441-4000 | Robert J Delaney, CRNA 1001 Towson Ave, Fort Smith, AR 72901-4921 Ph: (479) 441-4000 |
News Archive
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has received a notice of award for an NIH Small Business Technology Transfer (STTR) Phase I grant from the National Institute of Neurological Disorders and Stroke.
In recent research by Judith Grau-Expósito et al., scientists identify circulating virus-specific T cell responses during acute SARS-CoV-2 infection with functional, migratory, and apoptotic patterns modulated by viral proteins and associated with clinical outcome.
OPKO Health, Inc. today announced that it has completed the acquisition of Pharmacos Exakta, S.A. de C.V. ("Pharmacos Exakta"), a privately-owned Mexican pharmaceutical company engaged in the manufacture, marketing and distribution of ophthalmic and other pharmaceutical products for government and private markets since 1957. OPKO acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of OPKO Common Stock.
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.
Lifesaving diagnoses and actions, prompted by the anywhere, anytime availability of vital cardiac information, is now more accessible thanks to a wireless heart monitoring solution from Mednet Healthcare Technologies that is powered by AT&T's wireless technologies.
› Verified 8 days ago
Mrs. Kathryn Denyse Hass, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 7301 Rogers Ave, Fort Smith, AR 72903 Phone: 479-314-6000 | |
Dr. Shane Jamison, DNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12809 Diamond Ln, Fort Smith, AR 72916 Phone: 918-721-3264 | |
Alana Lea Vargas, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 6301 Ellsworth Rd, Fort Smith, AR 72903 Phone: 760-521-1872 | |
Ms. Jo Beth Bradshaw Dobbins, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 Towson Ave, Fort Smith, AR 72901 Phone: 479-441-5291 Fax: 479-441-4162 | |
James A Mcdaniel, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1115 S Waldron Rd, 107, Fort Smith, AR 72903 Phone: 479-452-1581 Fax: 479-452-2148 | |
Mr. Bradley Richad Leamy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12409 Havishum Ct, Fort Smith, AR 72916 Phone: 417-207-7003 | |
Mr. James Michael Peczuh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 Towson Ave, Sparks Regional Medical Center, Fort Smith, AR 72901 Phone: 479-441-4000 |